A psychedelic medicine performs well against depression
Summary
The Economist article reports on a psychedelic medicine showing positive results in treating depression, highlighting recent clinical trial outcomes, safety considerations, and regulatory considerations for broader use. It emphasizes the potential of psychedelic-assisted therapy while noting the need for careful evaluation of risks, patient selection, and long-term outcomes.